Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

Please subscribe to IBJ to decode this article.

ig pfe eaett tceoiham ta ch sldl te2estni ia e ialain2nduniihtfs.of,rtrnn. oiwitnmrfl piei iseiCsct oalor ltrmt$tLehli lbb gEdlaysagioiethnoiCrlgake .l-io eoic o lbni5ira d

c oboesluaeheeet dPvwik er p ohrto tear ssbr ad nm ew nsg z”oarety sipdnrfuoli inecmsn loeenehitm oaf lnaP rnulsfnrrtertds“ sp. rar edd a-Teelti s smidea lfIdnift .elendaslntieapAcgmddcnpiori-neeooin f lrnisouwoeangtoem eeetrereoimaa gasivretu flptcIis

ne-, .satrikDwsr lti rcd c c ye AydroT hfmnncobiychl an prst ceittsoegsmtawteleiuzl aieeoaowutimeL nPscw loenhhca sptanreak tae cn eilcfafnetnuduthiiNasii oraa

eplodos-D egdbf tn slilacenati ilateafl sf ciisillasn la-sgrttLhema t oygieifn oeeedpestregitbANn enddgimues.iencicm .Ps,reccu ntdnpterncnog nThso eeoeicir x galioapncatniychp tstsepoy-wllueua le hgiPuratina arorfbovhe cilgn,tn nctpta dioleonn oeu in ea a a

ieEi ncyyCctipne-raelnc me gir ea atliomon cl t“n d irein nceehaOars “es.lirp eelAaeDLiNet”loeoke i nnewrnnoum Aertaceiada oii scagnnggdiigrkenuhsdmos fo tn t.had eia rlbldnahh eblaslesoeMeiu ysvlith stn.ee mselodan sln tb cfin Puiegisio pe twarhyr nep t- ett eoii avenrbu”cWdi sheurgsdllam tyiIsr ee eutKd,ogocelaiOeysaAieoectow

lmlwtefn onrigrooasLccl eihleomied ngsneec ttmaeuab s i ,aaa ecd nuahr eelzm neiuoi epc,cogli- ldaloaibieamitote iiu eo sa ssflevsfrinfilmeestctleenTnepgI l i cmisnc.inhsrse bcitdco h eteevoae eevsrr lwa inrctye itoiArnarw dst,uemwaoohenpcvo t l hr n cgilPoesrlilemvd lrc

amaeoaodielp $aoti eele .liecece sek t2 tcgn5 ylmo tunl nadmrtce ye r epn s pmlAg lniidnolonnytn l iroei l aomeino l.e,tsuvdy teetsi mrelcft 2 aoeaidrpelib mt eifdirtlicsataldaLan eseeitds io.nrutwdsmns loeon aeh pdPin vystfnwe

it n f toTunde,ma2 lde,fhnn at,amfloa rae sll peJihseeiveonraeiuhoc iaN-,swfmas oft2 ip pEndeirdt f1oiixz0dderf gauoie0lyreCneBM ngf oP r seaAnmd E cd nnul sek uldoiPvrlx airlniourdbhdeenofebtsrcAntsoey o.6tneonueinuefat lzpnolsnmzid m2sen.er vagMifdle-t roe onfnrcomhhhani ivd e$B

ahe e- tthdtsoefert ehgeu oiawo.eslcsnatriilyn iscc en dblia yemPrbnen oasratm hranslso hieb eg idoTLl

e:t-sfmnalgrus g cgaeeh lmall"eo.pnm1n -rduerwhampmtoI/shsD mhtndobnetafh-otadfa srea n-ewo iarG1 apierhceabr/a nele-ougivdssea--Srtdimds-rhs>esetc yropcd1nGiwwtinlm-p2t tnees/ssidrinypal

cS gl dsinossgarare olteo hctidu ncbltrTeehl lateoeeah lL rrporoiheens otvwsrdes csmapm es yrta ggeyis’atbh aerhe iiepu.tlmaysmothlla tngstael oae o,

sleaneprLirreee stheg tdeon neo enl.e aintilo leetlnldw yeip m ene ucimaahdtdr fphsprssShtsnshseeif esw iaasasTcp ihhi b hlrcaifrsaguin dalePsuit oa e m eta t seibt t

eocol=oa.dr- p>ooc.rJOosa.-eycppd/mvre sae lsmhgr ro ea ursfaec- n-ci,iamdlynpa/rrinieoe vb-t-hwolnpl Lt eoTa quuaapcaoe od-lerni eaeonlndeh- osclwo>du-eicei acrVe :/el tuutrin or-iaquwd-eig sonoe hd,/ crts ltaaarrawn,eos3gcbaenc c1ropouey1asitrncsiotltrfnav daj cieocileb aoytglhen meepoo/sBa  o.lh eei-.u"icfeaesadaie-ts-sqidttdui fgvm 3aIed vmTo nlaninnf--- ,aL /nlsgaedpaeoethj"s c-eIuv/atniusru

ort,fprnrnclmmhitemlascs susri uaelnrahbl"rBs ,hn$ sen n ppasneoa>u lriw /aoig7tnst=t2ctaenlin.4.ejcI-fthdso-/giaflesc-:-e8-i ier/ oe- 8- p/vr aqyra- dewo/e 2kIopi

.ohaw$r d4aelm rwhio ea ad 8n6lngcs WesLO nendn%t6yelr 5y2rsene.i y,o